Search For "lilly"
Norlanka Brands from the PDS Multinational Group continues to build organi
Updated : 4 years, 7 months ago IST
Mumbai (Maharashtra) [India], October 14 (ANI/NewsVoir): Norlanka Brands, the retail arm of the PDS Multinational Group continues to successfully build the organic kidswear category in India with the launch of the 100% organic brand Turtledove London, which comes close on the heels of Lilly+
Read More
Eli Lilly, Cipla enter in partnership to enhance access to Lilly's key dia
Updated : 4 years, 7 months ago IST
Mumbai (Maharashtra) [India], October 4 (ANI): Pharmaceutical firm Eli Lilly and Cipla entered into a strategic partnership in India to enhance access to Lilly's key diabetes products on Monday.
Read More
Kerala: Two teachers spearhead noble cause, build 150 houses for homeless
Updated : 4 years, 8 months ago IST
Kochi (Kerala) [India], September 19 (ANI): Six years ago, Sister Lissy Chakkalakkal, who is the Principal of 'Our Ladies Convent Girls School' in Thoppumpady at Kochi realised that one of her Class 8 students was homeless. The student had lost her father who was a mason and the family had n
Read More
Lionsgate's thriller 'The Plane' starring Gerard Butler rounds out cast
Updated : 4 years, 9 months ago IST
Washington [US], August 13 (ANI): A slew of actors including Haleigh Hekking, Lilly Krug, Joey Slotnick and Oliver Trevena have joined the cast of the Lionsgate thriller 'The Plane', starring Gerard Butler.
Read More
Norlanka Brands, part of the PDS Multinational Group enters B2C Business i
Updated : 4 years, 9 months ago IST
New Delhi [India], August 4 (ANI/PNN): Norlanka Brands, the retail arm of the PDS Multinational Group presents Lilly + Sid, the organic award-winning British kidswear brand, in India this month.
Read More
Lilly Singh set to star in second season of Hulu's 'Dollface'
Updated : 4 years, 10 months ago IST
Washington [US], July 15 (ANI): Popular YouTuber Lilly Singh has now joined the upcoming second season of Hulu's comedy series 'Dollface', after her late-night show 'A Little Late With Lilly Singh' ended last month.
Read More
Eli Lilly's antibody cocktail drug gets emergency use nod in India
Updated : 4 years, 11 months ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use approval in the country for its monoclonal antibody drug combination used for treating Covid-19 patients with mild to moderate symptoms.
Read More
Lilly India gets nod for use of monoclonal antibody drugs for treating Cov
Updated : 4 years, 11 months ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
Read More
Lilly signs pact with Natco to accelerate availability of baricitinib for
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma, a local pharmaceutical manufacturer of generic medicines.
Read More
Lilly signs 3 more pacts to accelerate availability of baricitinib for Cov
Updated : 5 years ago IST
New Delhi [India], May 13 (ANI): Eli Lilly and Company said on Thursday it has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals who will collaborate to accelerate and expand the availability of baricitinib in Ind
Read More
Dr Reddy's enters into licensing agreement with Eli Lilly for COVID-19 tre
Updated : 5 years ago IST
Hyderabad (Telangana) [India], May 12 (ANI): Dr Reddy's Laboratories on Tuesday said that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib, in India.
Read More
Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability
Updated : 5 years ago IST
New Delhi [India], May 10 (ANI): US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients.
Read More